|
Volumn 25, Issue 23, 2015, Pages 5546-5550
|
Discovery of potent, selective, and orally bioavailable inhibitors of interleukin-1 receptor-associate kinase-4
|
Author keywords
Inflammation; Interleukin 1 receptor associate kinase 4; N Acyl 2 aminobenzimidazole
|
Indexed keywords
BENZIMIDAZOLE DERIVATIVE;
INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4;
2-AMINOBENZIMIDAZOLE;
INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE;
PROTEIN BINDING;
PROTEIN KINASE INHIBITOR;
ANIMAL EXPERIMENT;
ARTICLE;
BINDING AFFINITY;
CONTROLLED STUDY;
DRUG CLEARANCE;
DRUG PENETRATION;
DRUG SOLUBILITY;
DRUG SYNTHESIS;
IC50;
MOUSE;
NONHUMAN;
RAT;
STRUCTURE ACTIVITY RELATION;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
CHEMICAL STRUCTURE;
CHEMISTRY;
DRUG DEVELOPMENT;
DRUG EFFECTS;
ENZYME ACTIVATION;
ORAL DRUG ADMINISTRATION;
SYNTHESIS;
ADMINISTRATION, ORAL;
ANIMALS;
BENZIMIDAZOLES;
DRUG DISCOVERY;
ENZYME ACTIVATION;
INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES;
MOLECULAR STRUCTURE;
PROTEIN BINDING;
PROTEIN KINASE INHIBITORS;
RATS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84946544846
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2015.10.060 Document Type: Article |
Times cited : (10)
|
References (13)
|